Mostrar el registro sencillo del ítem

dc.contributor.author
Fuertes, Mercedes Beatriz  
dc.contributor.author
Kacha, Aalok K.  
dc.contributor.author
Kline, Justin  
dc.contributor.author
Woo, Seng Ryong  
dc.contributor.author
Kranz, David M.  
dc.contributor.author
Murphy, Kenneth M.  
dc.contributor.author
Gajewski, Thomas F.  
dc.date.available
2017-01-05T20:17:56Z  
dc.date.issued
2011-09  
dc.identifier.citation
Fuertes, Mercedes Beatriz; Kacha, Aalok K. ; Kline, Justin ; Woo, Seng Ryong ; Kranz, David M. ; et al.; Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells; Rockefeller Univ Press; Journal Of Experimental Medicine; 208; 10; 9-2011; 2005-2016  
dc.identifier.issn
0022-1007  
dc.identifier.uri
http://hdl.handle.net/11336/10886  
dc.description.abstract
Despite lack of tumor control in many models, spontaneous T cell priming occurs frequently in response to a growing tumor. However, the innate immune mechanisms that promote natural antitumor T cell responses are undefined. In human metastatic melanoma, there was a correlation between a type I interferon (IFN) transcriptional profile and T cell markers in metastatic tumor tissue. In mice, IFN-b was produced by CD11c(+) cells after tumor implantation, and tumor-induced T cell priming was defective in mice lacking IFN-a/bR or Stat1. IFN signaling was required in the hematopoietic compartment at the level of host antigen-presenting cells, and selectively for intratumoral accumulation of CD8a(+) dendritic cells, which were demonstrated to be essential using Batf3(-/-) mice. Thus, host type I IFNs are critical for the innate immune recognition of a growing tumor through signaling on CD8alfa(+) DCs.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Rockefeller Univ Press  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Interferon  
dc.subject
Tumor  
dc.subject
Cd8 T Cell  
dc.subject
Dendritic Cell  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2016-12-30T13:42:57Z  
dc.identifier.eissn
1540-9538  
dc.journal.volume
208  
dc.journal.number
10  
dc.journal.pagination
2005-2016  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Birmingham, Alabama  
dc.description.fil
Fil: Fuertes, Mercedes Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University Of Chicago; Estados Unidos  
dc.description.fil
Fil: Kacha, Aalok K. . University Of Chicago; Estados Unidos  
dc.description.fil
Fil: Kline, Justin . University Of Chicago; Estados Unidos  
dc.description.fil
Fil: Woo, Seng Ryong . University Of Chicago; Estados Unidos  
dc.description.fil
Fil: Kranz, David M. . University Of Illinois; Estados Unidos  
dc.description.fil
Fil: Murphy, Kenneth M. . Washington University in St. Louis; Estados Unidos  
dc.description.fil
Fil: Gajewski, Thomas F. . University Of Chicago; Estados Unidos  
dc.journal.title
Journal Of Experimental Medicine  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://jem.rupress.org/content/208/10/2005  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http:/dx.doi.org/10.1084/jem.20101159